On the other hand, the recent successes and relatively lower genomic modification risk by protein transduction through fusion with a cell penetrating peptide prompted us to evaluate the effectiveness of Lnk protein in stopping leukemia cell growth in vitro. This evidence concerns the gene SH2B3 and leukemia.